| Brittany Dibetta Belk, CRNA | |
|
215 Republic Ave, Apt 6105, Lafayette, LA 70508-6993 | |
| (504) 451-4464 | |
| Not Available |
| Full Name | Brittany Dibetta Belk |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | 215 Republic Ave, Lafayette, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013450048 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 114742 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| King's Daughters Medical Center-brookhaven | Brookhaven, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kings Daughters Medical Center | 3072575539 | 42 |
News Archive
Hybrigenics (ALHYG), a bio-pharmaceutical group with a focus on research and development of new cancer treatments and a fully-owned subsidiary specialized in protein interactions services, today announces it has received EUR 800,000 as the second and last payment of a EUR 1.4 million refundable grant contract originally signed with France's innovation agency, Oseo Innovation, in 2008.
Yale researchers describe a breakthrough in safe and effective administration of potential antiviral drugs - small interfering RNA (siRNA) molecules that silence genes - the first step in development of a new kind of treatment for sexually transmitted diseases (STDs). The work is reported May 4 as an advance online publication of Nature Materials.
Duke University Medical Center researchers have discovered that patients who have two specific gene variants are more than three times as likely to suffer a stroke after heart surgery.
Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.
› Verified 4 days ago
| Entity Name | Jackson Anesthesia Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780737577 PECOS PAC ID: 3870585904 Enrollment ID: O20040331000285 |
News Archive
Hybrigenics (ALHYG), a bio-pharmaceutical group with a focus on research and development of new cancer treatments and a fully-owned subsidiary specialized in protein interactions services, today announces it has received EUR 800,000 as the second and last payment of a EUR 1.4 million refundable grant contract originally signed with France's innovation agency, Oseo Innovation, in 2008.
Yale researchers describe a breakthrough in safe and effective administration of potential antiviral drugs - small interfering RNA (siRNA) molecules that silence genes - the first step in development of a new kind of treatment for sexually transmitted diseases (STDs). The work is reported May 4 as an advance online publication of Nature Materials.
Duke University Medical Center researchers have discovered that patients who have two specific gene variants are more than three times as likely to suffer a stroke after heart surgery.
Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.
› Verified 4 days ago
| Entity Name | Kings Daughters Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043245368 PECOS PAC ID: 3072575539 Enrollment ID: O20041028000174 |
News Archive
Hybrigenics (ALHYG), a bio-pharmaceutical group with a focus on research and development of new cancer treatments and a fully-owned subsidiary specialized in protein interactions services, today announces it has received EUR 800,000 as the second and last payment of a EUR 1.4 million refundable grant contract originally signed with France's innovation agency, Oseo Innovation, in 2008.
Yale researchers describe a breakthrough in safe and effective administration of potential antiviral drugs - small interfering RNA (siRNA) molecules that silence genes - the first step in development of a new kind of treatment for sexually transmitted diseases (STDs). The work is reported May 4 as an advance online publication of Nature Materials.
Duke University Medical Center researchers have discovered that patients who have two specific gene variants are more than three times as likely to suffer a stroke after heart surgery.
Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brittany Dibetta Belk, CRNA 215 Republic Ave, Apt 6105, Lafayette, LA 70508-6993 Ph: () - | Brittany Dibetta Belk, CRNA 215 Republic Ave, Apt 6105, Lafayette, LA 70508-6993 Ph: (504) 451-4464 |
News Archive
Hybrigenics (ALHYG), a bio-pharmaceutical group with a focus on research and development of new cancer treatments and a fully-owned subsidiary specialized in protein interactions services, today announces it has received EUR 800,000 as the second and last payment of a EUR 1.4 million refundable grant contract originally signed with France's innovation agency, Oseo Innovation, in 2008.
Yale researchers describe a breakthrough in safe and effective administration of potential antiviral drugs - small interfering RNA (siRNA) molecules that silence genes - the first step in development of a new kind of treatment for sexually transmitted diseases (STDs). The work is reported May 4 as an advance online publication of Nature Materials.
Duke University Medical Center researchers have discovered that patients who have two specific gene variants are more than three times as likely to suffer a stroke after heart surgery.
Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.
› Verified 4 days ago
Charles L. Papadakes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1103 Kaliste Saloom Rd, Suite 304, Lafayette, LA 70508 Phone: 337-988-5646 Fax: 337-988-4298 | |
Mr. Stephen Kyle Chauvin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 314 Youngsville Hwy, Lafayette, LA 70508 Phone: 337-706-1500 | |
Paula L. Simon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4200 W Congress St, Suite 3200, Lafayette, LA 70506 Phone: 337-981-3546 | |
Mr. Bowen J Landry, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 611 Saint Landry St, Lafayette, LA 70506 Phone: 337-289-2966 Fax: 337-289-2776 | |
Dexter Paul Guidry Ii, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 4212 W Congress St, Suite 3200, Lafayette, LA 70506 Phone: 337-981-3546 Fax: 337-988-4298 | |
Mr. Jude L Guillory, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1103 Kaliste Saloom Rd, Suite 304, Lafayette, LA 70508 Phone: 337-988-5646 Fax: 337-988-4298 |